arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

CalciMedica, Inc.

CALC

$0.69 ▼ -0.05 (-6.54%) at close

30 Visible periods

19 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Neutral Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, CalciMedica, Inc. shows mixed fundamentals. Return on Invested Capital remain bright spots. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $10.9M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 401.5% ↗

FCF / Share $-0.31

Trailing P/E 2.2x

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

30-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$4.98M

↑ +146.2% —

FCF / Share Free cash flow per share

$-0.31

↑ +11.3% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

Return on Invested CapitalReturn on Invested Capital of 348.2% is excellent on an absolute basis (target > 10%)

warning

Bearish Risks

Interest CoverageInterest Coverage of -21.27x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.72x is caution on an absolute basis (target > 1x)

Health Breakdown

Financial Health

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
EPS Growth YoY (%)	N/M	-102.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-4.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-11.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-47.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	39.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	67.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	97.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	97.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	N/M	-8068.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-10052.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	-152.7% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	-2.7% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	N/M	-431.3% Weak ↓ Weak Declining Year-over-year change in net income	-431.3% Weak ↓ Weak Declining Year-over-year change in net income	-90.0% Weak ↓ Weak Declining Year-over-year change in net income	N/M	68.3% Excellent ↑ Excellent Improving Year-over-year change in net income	68.3% Excellent ↑ Excellent Improving Year-over-year change in net income	11.4% Fair ↑ Fair Improving Year-over-year change in net income	5.2% Fair ↑ Fair Improving Year-over-year change in net income	-46.9% Weak ↓ Weak Declining Year-over-year change in net income	-46.9% Weak ↓ Weak Declining Year-over-year change in net income	-46.9% Weak ↓ Weak Declining Year-over-year change in net income	10.9% Fair Fair Year-over-year change in net income	-23.8% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	11.3% Fair Fair Year-over-year change in free cash flow	—	—	—	28.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	92.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
FCF / Net Income (x)	-0.98x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.32x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	-36.27x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.28x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-2.89x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.16x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.39x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	401.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	52.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	1656.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-85.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-47.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-50.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-41.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-32.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-80.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	3.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	4.1% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.1% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	5.6% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	8.1% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	8.8% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-65.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-37.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-30.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-64.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-92.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-16.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-12.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-12.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-9.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-25.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	—	162.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+980%)	—	-82.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-651%)	-46.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-409%)	-29.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-297%)	1.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-90%)	0.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-94%)	0.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-95%)	-50.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-439%)	-158.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1158%)	-118.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-893%)	-87.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-684%)	-2.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-113%)	5.1% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-66%)	5.2% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-65%)	-18.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-220%)	-13.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	-15.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-206%)	-14.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-197%)	-13.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-190%)	-9.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-8.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	6.7% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	7.1% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-53%)	10.0% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-33%)	6.8% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	-17.59x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-8.16M	$-11.52M	$-5.47M	$-5.92M	$-12.56M	$-7.93M	$-9.15M	$-5.06M	$-6.75M	$-5.53M	$-11.64M	$-19.08M	$-24.39M	$-1.33M	—	—	$-8.36M	$-13.36M	—	—	$-10.59M	$-33.42M	—	—	—	$-15.87M	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Basic EPS, GAAP (USD)	$0.31	$-0.69	$-0.52	$-0.40	$-0.36	$-0.34	$-0.50	$-0.36	$0.01	$-0.23	$-0.82	$-1.11	$-23.43	$2.08	$-31.04	$-36.55	—	$-0.41	$-0.38	$-0.36	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.31	—	$-0.32	$-0.45	$-0.35	—	—	—	$-0.48	—	—	—	$-6.51	—	—	—	—	—	$-0.27	$-0.38	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.07	$-0.43	$-0.02	$0.44	$0.78	$1.07	$0.84	$1.29	$1.61	$1.42	$2.14	$2.86	$3.89	—	—	—	—	$3.04	$3.39	$3.72	—	$4.52	—	—	—	$-75.07	—	—	—	—
Tangible Book Value per Share (USD)	$-0.07	$-0.43	$-0.02	$0.44	$0.78	$1.07	$0.84	$1.29	$1.61	$1.42	$2.14	$2.86	$3.89	—	—	—	—	$3.04	$3.39	$3.72	—	$4.52	—	—	—	$-75.07	—	—	—	—
Basic Weighted Avg Shares (shares)	15.82M	—	15.08M	15.00M	14.12M	—	11.13M	11.13M	9.75M	—	5.67M	5.66M	823,069	—	83,154	82,923	—	—	21.29M	21.15M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$3.24M	$9.75M	$11.17M	$15.49M	$20.76M	$15.98M	$11.90M	$16.53M	$22.32M	$7.58M	$11.59M	$16.02M	$21.85M	$-3.05M	—	—	$53.99M	$63.02M	—	—	$82.54M	$92.24M	—	—	—	$24.02M	—	—	—	—
Total Equity (USD)	$-1.10M	$-6.64M	$-268.00K	$6.10M	$10.89M	$14.41M	$9.03M	$13.84M	$17.25M	$8.16M	$12.16M	$16.22M	$22.02M	$-71.30M	$-71.79M	$-69.97M	$56.26M	$65.02M	$72.14M	$78.67M	$84.56M	$94.79M	$90.63M	$-116.16M	$-110.51M	$-102.95M	$-92.87M	$-83.04M	$-72.92M	$-66.79M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Depreciation Expense (USD)	$7.00K	$5.00K	$12.00K	$14.00K	$15.00K	$14.00K	$15.00K	$15.00K	$15.00K	$19.00K	$12.00K	$14.00K	$13.00K	$13.00K	$13.00K	$13.00K	$122.00K	$136.00K	$136.00K	$129.00K	$118.00K	$111.00K	$96.00K	$95.00K	$93.00K	$84.00K	—	—	—	—
Net Income, GAAP (USD)	$4.98M	$-10.76M	$-5.04M	$-5.04M	$-5.04M	$-4.26M	$130.00K	$130.00K	$130.00K	$-4.15M	$-19.29M	$-19.29M	$-19.29M	$1.42M	$-3.63M	$-3.63M	$-10.15M	$-8.68M	$-11.45M	$-11.45M	$-11.45M	$-9.15M	$-7.79M	$-7.79M	$-7.79M	$-10.27M	$-6.29M	—	—	—
Operating Cash Flow (USD)	$-4.86M	$-4.85M	$-4.78M	$-6.67M	$-4.88M	$-4.97M	—	—	$-4.71M	$-3.61M	—	—	$-5.36M	$-4.09M	$-1.83M	$-2.22M	$-6.52M	$-8.96M	$-5.50M	$-7.78M	$-9.26M	$-9.77M	$-5.36M	$-6.22M	$-10.71M	$-9.87M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters

CalciMedica, Inc.

Analytical Summary

30-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare CALC with peers